• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Orhub Inc (OP: ORHB )

    0.0100 -0.0001 (-0.99%)
    Streaming Delayed Price Updated: 3:47 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Orhub Inc

    < Previous 1 2 3 Next >
    ORHub Acquires PUR Biologics, Entering the Global Medical Device Market
    "PUR's technologies will bring new solutions for pain elimination and osteoarthritis." IRVINE, CA / ACCESSWIRE / April 25, 2022 / ORHub, Inc. (OTC PINK:ORHB) announced today it has purchased 100% of... 
    From ORHUB, Inc.
    Via AccessWire
    Topics Intellectual Property
    Exposures Intellectual Property
    ORHub Prepares To Finalize Acquisition Of Pur Biologics
    "ORHub plans to use PUR's patented technologies to treat osteoarthritis & joint cartilage" IRVINE, CA / ACCESSWIRE / April 15, 2022 / ORHub, Inc. (OTC Pink:ORHB) announced today it has reached a... 
    From ORHUB, Inc.
    Via AccessWire
    ORHub, Inc. the Courts Rule To "Dismiss With Prejudice" the Lawsuit Brought by Frederic J. Buonincontri & Axt Analytics, LLC
    IRVINE, CA / ACCESSWIRE / April 5, 2022 / ORHub, Inc. (OTC PINK:ORHB) ORHub announced today it has received the court ruling of an "ORDER DISMISSING WITH PREJUDICE" the litigation brought by Frederic... 
    From ORHub, Inc.
    Via AccessWire
    Topics Lawsuit
    Exposures Financial Legal
    Orhub's Story Proves the Power of a Winning Culture
    IRVINE, CA / ACCESSWIRE / March 14, 2022 / An Important message from the Chairman & CEO Dear Shareholders, It is an exciting time for ORHub. Our vision for the Company began in the operating room where... 
    From ORHUB, Inc.
    Via AccessWire
    ORHub Executes Letter Of Intent For Acquisition
    "ORHub continues to evaluate synergistic opportunities which add revenue and broaden market opportunity." IRVINE, CA / ACCESSWIRE / March 7, 2022 / ORHub, Inc. (OTC PINK:ORHB). ORHub today announced it... 
    From ORHUB, Inc.
    Via AccessWire
    ORhub Announces Sean McMenamin as An Independent Member of The Board
    IRVINE, CA / ACCESSWIRE / December 6, 2021 / ORHub, Inc. (OTC PINK:ORHB) ORHub today announces Sean McMenamin's addition to the Board of Directors. Mr. McMenamin will help to provide board level... 
    From ORHUB, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    ORHUB Enters The Holidays, Generating Revenue Through Continued Customer Agreement
    Six-figure revenue event & customer requests for FutureOR TM , demonstrate ORHub's effort to "Transform the Business of Surgery TM " is on target. IRVINE, CA / ACCESSWIRE / December 1, 2021 / ORHub,... 
    From ORHUB, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    ORHub Prepares for New Platform Launch
    "ORHub aims for Q2, 2022 to bring total implant accountability to the medical device & surgical industry" IRVINE, CA / ACCESSWIRE / November 29, 2021 / ORHub, Inc. (OTC PINK:ORHB) has invested in... 
    From ORHUB, Inc.
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    ORHub Remains Capitalized & Focused On The Future
    "ORHubTM has laid the foundation to support its new business design & forward strategy." IRVINE, CA / ACCESSWIRE / November 23, 2021 / ORHub, Inc. (OTC PINK:ORHB) provides a 2021 update and announces... 
    From ORHUB, Inc.
    Via AccessWire
    Topics Artificial Intelligence Regulatory Compliance
    Exposures Artificial Intelligence Legal Regulatory
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.